Literature DB >> 20583999

Epithelial marker expression in Salzmann nodular degeneration shows characteristics of limbal transient amplifying cells and alludes to an involvement of the epithelium in its pathogenesis.

Philipp Eberwein1, Sonja Hiss, Claudia Auw-Haedrich, Rainer Sundmacher, Katharina Hauer, Daniel Boehringer, Peter Meier, Thomas Reinhard.   

Abstract

PURPOSE: To look at the epithelial nature of Salzmann nodular degeneration (SND) and its possible relation with the aetiology of the subepithelial collagen deposition.
METHODS: Histological slides of 28 patients with SND were analysed for limbal and central corneal epithelial markers. Expression pattern of these markers in the basal layer of the epithelium was analysed and compared to the expression pattern in central corneal and limbal epithelium. Statistical analysis was performed by means of analysis of variance.
RESULTS: Expression of the epithelial stem cell marker ABCG2 and p63 was low in SND. Expression of CK12, a marker for terminally differentiated epithelium, was low, as well. But, CK19 and Enolase-alpha expressions were significantly increased and resembled the expression pattern of transient amplifying cells (TAC) of the limbus.
CONCLUSION: The epithelium in SND shows similar characteristics as TAC of the limbus and seems to be metabolically more active than the differentiated central corneal epithelium. This could be related to the deposition of subepithelial collagen fibrils seen in SND and points out a possible involvement of the corneal epithelium in the aetiology of Salzmann nodular degeneration.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20583999     DOI: 10.1111/j.1755-3768.2010.01887.x

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  5 in total

1.  [Surgical removal of Salzmann's nodules using intraoperative mitomycin C].

Authors:  D Böhringer; D Widmer; P Eberwein; P Maier; T Reinhard
Journal:  Ophthalmologe       Date:  2016-09       Impact factor: 1.059

2.  Superficial keratectomy, PTK, and mitomycin C as a combined treatment option for Salzmann's nodular degeneration: a follow-up of eight eyes.

Authors:  Riad Khaireddin; Toam Katz; Rahul B Baile; Gisbert Richard; Stephan J Linke
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-04-05       Impact factor: 3.117

3.  [Salzmann's nodular degeneration. Mostly an epithelial corneal dystrophy].

Authors:  R Sundmacher
Journal:  Ophthalmologe       Date:  2012-04       Impact factor: 1.059

4.  Salzmann nodular degeneration: prevalence, impact, and management strategies.

Authors:  Vikram Paranjpe; Anat Galor; Pedro Monsalve; Sander R Dubovy; Carol L Karp
Journal:  Clin Ophthalmol       Date:  2019-07-25

5.  Atypical Presentation of Salzmann Nodule: A Case Report and Literature Review.

Authors:  Mohanna Y Aljindan; Malak A Bamashmoos; Reem A AlShamlan; Amal A AlOdaini; Hanoof A Alabdullatif
Journal:  Cureus       Date:  2021-06-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.